Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions

References

• Choy E. Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012;5:v3–v11.
   Google Scholar
• Boissier MC, Semerano L, Challal S, et al. Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction. J Autoimmun 2012;39:222–228.
   PubMed Web of Science ®Google Scholar
• Vital EM, Emery P. The development of targeted therapies in rheumatoid arthritis. J Autoimmun 2008;31:219–227.
   PubMed Web of Science ®Google Scholar
• Filer A. The fibroblast as a therapeutic target in rheumatoid arthritis. Curr Opin Pharmacol 2013;13:413–419.
   PubMed Web of Science ®Google Scholar
• Brentano F, Kyburz D, Schorr O, et al. The role of toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 2005;233:90–96.
   PubMed Web of Science ®Google Scholar
• Cho ML, Ju JH, Kim HR, et al. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 2007;108:121–128.
   PubMed Web of Science ®Google Scholar
• Jung YO, Cho ML, Lee SY, et al. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Immunol Lett 2009;123:138–143.
   PubMed Web of Science ®Google Scholar
• Turner JD, Filer A. The role of the synovial fibroblast in rheumatoid arthritis pathogenesis. Curr Opin Rheumatol 2015;27:175–182.
   PubMed Web of Science ®Google Scholar
• Hu F, Li Y, Zheng L, et al. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis. PLoS ONE 2014;9:e100266.
   Google Scholar
• Pierer M, Rethage J, Seibl R, et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004;172:1256–1265.
   PubMed Web of Science ®Google Scholar
• Philippe L, Alsaleh G, Suffert G, et al. TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol 2012;188:454–461.
   PubMed Web of Science ®Google Scholar
• Sommerfelt RM, Feuerherm AJ, Skuland T, Johansen B. Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes. PLoS ONE 2015;10:e0119088.
   Google Scholar
• Zhu W, Jiang C, Xu J, et al. Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-α initiated p38 MAPK and NF-κB pathways. Clin Immunol 2015;156:141–153.
   PubMed Web of Science ®Google Scholar
• Brentano F, Schorr O, Gay RE, et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 2005;52:2656–2665.
   PubMed Web of Science ®Google Scholar
• Karpus ON, Heutinck KM, Wijnker PJM, et al. Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts. PLoS ONE 2012;7:e35606.
   Google Scholar
• Carrión M, Juarranz Y, Pérez-García S, et al. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum 2011;63:1626–1636.
   Google Scholar
• Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008;275:4448–4455.
   PubMed Web of Science ®Google Scholar
• Lee DG, Woo JW, Kwok SK, et al. MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis. Exp Mol Med 2013;45:e20.
   Google Scholar
• Jung YO, Cho ML, Kang CM, et al. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol Lett 2007;109:21–27.
   PubMed Web of Science ®Google Scholar
• Alsaleh G, Sparsa L, Chatelus E, et al. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010;12:R135.
   Google Scholar
• Xu WD, Zhang M, Feng CC, et al. IL-32 with potential insights into rheumatoid arthritis. Clin Immunol 2013;147:89–94.
   PubMed Web of Science ®Google Scholar
• Carrion M, Juarranz Y, Martinez C, et al. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology 2013;52:2177–2186.
   PubMed Web of Science ®Google Scholar
• Lau LF. CCN1/CYR61: The very model of a modern matricellular protein. Cell Mol Life Sci 2011;68:3149–3163.
   PubMed Web of Science ®Google Scholar
• Kular L, Pakradouni J, Kitabgi P, et al. The CCN family: A new class of inflammation modulators? Biochimie 2011;93:377–388.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhou Z, Huo R, et al. Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis. J Immunol 2012;188:5776–5784.
   PubMed Web of Science ®Google Scholar
• Zhu X, Song Y, Huo R, et al. Cyr61 participates in the pathogenesis of rheumatoid arthritis by promoting proIL-1β production by fibroblast-like synoviocytes through an AKT-dependent NF-κB signaling pathway. Clin Immunol 2015;157:187–197.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu J, Cao Q, et al. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 2009;60:3602–3612.
   PubMed Web of Science ®Google Scholar
• Zhu X, Xiao L, Huo R, et al. Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2013;15:R187.
   Google Scholar
• Umar S, Hedaya O, Singh AK, Ahmed S. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Toxicol Appl Pharmacol 2015;287:299–305.
   PubMed Web of Science ®Google Scholar
• Noss EH, Chang SK, Watts GFM, Brenner MB. Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement. Arthritis Rheum 2011;63:3768–3778.
   PubMed Web of Science ®Google Scholar
• Liu FL, Wu CC, Chang DM. TACE-dependent amphiregulin release is induced by IL-1 and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatology 2014;53:260–269.
   PubMed Web of Science ®Google Scholar
• Kyung CS, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev 2010;233:256–266.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang L, Kong W, et al. Umbilical cord-derived mesenchymal stem cells inhibit cadherin-11 expression by fibroblast-like synoviocytes in rheumatoid arthritis. J Immunol Res 2015;2015:1–10.
   Google Scholar
• Eseonu OI, De Bari C. Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis. Rheumatology v 2015;54:210–218.
   PubMed Web of Science ®Google Scholar
• Yoo SA, Yoon HJ, Kim HS, et al. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: A link between angiogenesis and inflammation. Arthritis Rheum 2009;60:345–354.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim KJ, Kim WU, Cho CS. Interaction of mesenchymal stem cells with fibroblast-like synoviocytes via Cadherin-11 promotes angiogenesis by enhanced secretion of placental growth factor. J Immunol 2014;192:3003–3010.
   PubMed Web of Science ®Google Scholar
• Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005;32:270–279.
   PubMed Web of Science ®Google Scholar
• Yoo SA, Park JH, Hwang SH, et al. Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes. J Immunol 2015;194:2513–2521.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yang RS, Lin TH, et al. Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-κB and COX-2 pathways in rheumatoid arthritis synovial fibroblast. Eur J Pharmacol 2013;714:388–396.
   PubMed Web of Science ®Google Scholar
• Tu HJ, Lin TH, Chiu YC, et al. Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. J Cell Physiol 2013;228:983–990.
   PubMed Web of Science ®Google Scholar
• Ribatti D. Tumor refractoriness to anti-VEGF therapy. Oncotarget 2016;7:46668–46677.
   Web of Science ®Google Scholar
• Bossaller L, Rothe A. Monoclonal antibody treatments for rheumatoid arthritis. Expert Opin Biol Ther 2013;13:1257–1272.
   PubMed Web of Science ®Google Scholar
• O'Shea JJ, Laurence A, McInnes IB. Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nat Rev Rheumatol 2013;9:173–182.
   PubMed Web of Science ®Google Scholar
• Kim KJ, Cho CS, Kim WU. Role of placenta growth factor in cancer and inflammation. Exp Mol Med 2012;44:10–19.
   PubMed Web of Science ®Google Scholar
• Konisti S, Kiriakidis S, Paleolog EM. Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012;8:153–162.
   PubMed Web of Science ®Google Scholar
• Kim HR, Kim KW, Kim BM, et al. The effect of vascular endothelial growth factor on osteoclastogenesis in Rheumatoid arthritis. Plos One 2015;10:e0124909.
   Google Scholar
• Ramamoorthi G, Sivalingam N. Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy. Tumour Biol 2014;35:7295–7305.
   PubMed Web of Science ®Google Scholar
• Cho ML, Min SY, Chang SH, et al. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression. Immunol Lett 2006;105:159–166.
   PubMed Web of Science ®Google Scholar
• Yasui T, Kadono Y, Nakamura M, et al. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. J Bone Miner Res 2011;26:1447–1456.
   PubMed Web of Science ®Google Scholar
• Shibuya H, Yoshitomi H, Murata K, et al. TNFα, PDGF, and TGFβ synergistically induce synovial lining hyperplasia via inducible PI3Kδ. Mod Rheumatol 2015;25:72–78.
   PubMed Web of Science ®Google Scholar
• Stanford SM, Aleman Muench GR, Bartok B, et al. TGFβ responsive tyrosine phosphatase promotes rheumatoid synovial fibroblast invasiveness. Ann Rheum Dis 2016;75:295–302.
   PubMed Web of Science ®Google Scholar
• Lauzier A, Charbonneau M, Paquette M, et al. Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis. Arthritis Res Ther 2012;14:R159.
   Google Scholar
• Ekwall AKH, Whitaker JW, Hammaker D, et al. The Rheumatoid arthritis risk gene LBH regulates growth in fibroblast-like synoviocytes. Arthritis Rheumatol 2015;67:1193–1202.
   PubMed Web of Science ®Google Scholar
• Van Steendam K, Tilleman K, De Ceuleneer M, et al. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther 2010;12:R132.
   Google Scholar
• Koning F, Thomas R, Rossjohn J, Toes RE. Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol 2015;11:450–461.
   PubMed Web of Science ®Google Scholar
• Fan LY, He DY, Wang Q, et al. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 2012;41:354–358.
   PubMed Web of Science ®Google Scholar
• Shelef MA, Bennin DA, Mosher DF, Huttenlocher A. Citrullination of fibronectin modulates synovial fibroblast behavior. Arthritis Res Ther 2012;14:R240.
   Google Scholar
• Lefevre S, Meier FMP, Neumann E, Muller-Ladner U. Role of synovial fibroblasts in rheumatoid arthritis. Curr Pharm Des 2015;21:130–141.
   PubMed Web of Science ®Google Scholar
• Asano T, Iwasaki N, Kon S, et al. α9β1 integrin acts as a critical intrinsic regulator of human rheumatoid arthritis. Rheumatology 2014;53:415–424.
   PubMed Web of Science ®Google Scholar
• Choi HM, Lee YA, Lee SH, et al. Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthritis Res Ther 2009;11:R161.
   Google Scholar
• Takakubo Y, Oki H, Naganuma Y, et al. Distribution of podoplanin in synovial tissues in rheumatoid arthritis patients using biologic or conventional disease-modifying anti-rheumatic drugs. Curr Rheumatol Rev 2016; doi:10.2174/1573397112666160331143607
   Google Scholar
• Renart J, Carrasco-Ramírez P, Fernández-Muñoz B, et al. New insights into the role of podoplanin in epithelial-mesenchymal transition. Int Rev Cell Mol Biol 2015;317:185–239.
   PubMedGoogle Scholar
• Del Rey MJ, Faré R, Izquierdo E, et al. Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk. PLoS ONE 2014;9:e99607.
   Google Scholar
• Wigerup C, Påhlman S, Bexell D. Review: Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther 2016; doi:10.1016/j.pharmthera.2016.04.009
   Web of Science ®Google Scholar
• Del Rey MJ, Izquierdo E, Caja S, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 2009;60:2926–2934.
   PubMed Web of Science ®Google Scholar
• Wang Z, Dabrosin C, Yin X, et al. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 2015;35(Suppl):S224–S243.
   Google Scholar
• Hu F, Mu R, Zhu J, et al. Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis 2014;73:928–936.
   PubMed Web of Science ®Google Scholar
• Charbonneau M, Harper K, Grondin F, et al. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. J Biol Chem 2007;282:33714–33724.
   PubMed Web of Science ®Google Scholar
• Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol 2016;46:742–751.
   Web of Science ®Google Scholar
• Hu F, Shi L, Mu R, et al. Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis. PLoS ONE 2013;8:e72650.
   Google Scholar
• Lee YA, Choi HM, Lee SH, et al. Hypoxia differentially affects IL-1 -stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1 -dependent manner. Rheumatology 2012;51:443–450.
   PubMed Web of Science ®Google Scholar
• Li GQ, Zhang Y, Liu D, et al. PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial–mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis. Mol Cell Biochem 2013;372:221–231.
   PubMed Web of Science ®Google Scholar
• Gao W, McCormick J, Connolly M, et al. Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Ann Rheum Dis 2015;74:1275–1283.
   PubMed Web of Science ®Google Scholar
• Gao W, Sweeney C, Connolly M, et al. Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2012;64:2104–2113.
   PubMed Web of Science ®Google Scholar
• Wang C, Yao H, Chen L, et al. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis. Arthritis Rheum 2012;64:1818–1827.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee SW, Kim HY, et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. Eur J Immunol 2015;45:1216–1227.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Chae CS, Kwak JS, et al. Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Bio 2014;12:e1001881.
   Google Scholar
• Li X, Yuan F, Lu W, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 2010;397:131–135.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Takayanagi H. Regulation of bone by the adaptive immune system in arthritis. Arthritis Res Ther 2011;13:219.
   PubMed Web of Science ®Google Scholar
• Sadik CD, Kim ND, Alekseeva E, Luster AD. IL-17RA signaling amplifies antibody-induced arthritis. PLoS ONE 2011;6:e26342.
   Google Scholar
• Van Hamburg JP, Corneth OBJ, Paulissen SMJ, et al. IL-17/Th17 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis 2013;72:1700–1707.
   PubMed Web of Science ®Google Scholar
• Marotte H, Ruth JH, Campbell PL, et al. Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology 2010;49:467–479.
   PubMed Web of Science ®Google Scholar
• Lee SY, Yoon BY, Kim JI, et al. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Immunology 2014;141:353–361.
   PubMed Web of Science ®Google Scholar
• Paulissen SMJ, Van Hamburg JP, Davelaar N, et al. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23. J Immunol 2013;191:1364–1372.
   PubMed Web of Science ®Google Scholar
• Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593–2603.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang Y, Qian Y, et al. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway. Mol Immunol 2013;53:227–236.
   PubMed Web of Science ®Google Scholar
• Park YE, Woo YJ, Park SH, et al. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis. Immunol Lett 2011;140:97–103.
   PubMed Web of Science ®Google Scholar
• Heo YJ, Oh HJ, Jung YO, et al. The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1. Arthritis Res Ther 2011;13:R113.
   Google Scholar
• Moon YM, Yoon BY, Her YM, et al. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther 2012;14:R246.
   Google Scholar
• Heinhuis B, Koenders MI, Van Riel PL, et al. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis 2011;14:660–667.
   Google Scholar
• Morgan R, Endres J, Behbahani-Nejad N, et al. Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: Role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity: T cell chemotaxis to CD13 from FLS in RA. Arthritis Rheumatol 2015;67:74–85.
   PubMed Web of Science ®Google Scholar
• Gaffen SL. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep 2009;11:365–370.
   PubMedGoogle Scholar
• Yan C, Kong D, Ge D, et al. Mitomycin C induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via a mitochondrial-mediated pathway. Cell Physiol Biochem 2015;35:1125–1136.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kwok SK, Son HJ, et al. IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res Ther 2013;15:R31.
   Google Scholar
• Lee SY, Yoon BY, Kim JI, et al. Interleukin-17 increases the expression of toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Immunology 2014;141:353–361.
   PubMed Web of Science ®Google Scholar